Our Story
W e are the leading genomic care delivery company — personalizing health care for all through on-demand access to genetic insights and genomic medicine. We operate as an independent virtual medical practice, powered by a digital health technology platform. By partnering with health systems, providers, health plans, employers, labs and biopharma, we expand the reach and impact of precision medicine.
Genome Medical was founded in 2016 by genetics industry leaders Lisa Alderson, MBA; Randy Scott, PhD, the executive chairman of Invitae and founder of Genomic Health; and Robert C. Green, MD, MPH, an associate member of the Broad Institute, a professor of medicine at Harvard Medical School and a medical geneticist who directs the Genomes2People Research Program at Brigham and Women’s Hospital.
”Genome Medical is a mission-driven organization bringing genomic medicine to everyday care. We are delivering the future of health care today through our nationwide network of clinical genetic experts and our efficient genomic care delivery platform. Our team is dedicated to improving patient health and reducing the cost of health care delivery.
Lisa AldersonCo-Founder
Investors
Genome Medical is privately funded. The company has raised more than $120 million through several rounds of financing, with its most recent Series C financing being led by Casdin Capital. In addition to Casdin, the company has a strong group of investors, including Canaan, Echo Health Ventures, Illumina Ventures, Kaiser Permanente Ventures, GV, LRV Health, Samsung, HealthInvest Equity Partners, Amgen Ventures, Perceptive Advisors, Revelation Partners and others.
